A phase I, dose-finding study of sunitinib in combination with irinotecan in patients with advanced solid tumours

被引：0
|
作者：
E Boven
C Massard
J P Armand
C Tillier
V Hartog
N M Brega
A M Countouriotis
A Ruiz-Garcia
J C Soria
机构：
[1] VU University Medical Center,Department of Medical Oncology
[2] Institut Gustave Roussy,Department of Medicine
[3] Pfizer Italia Srl,undefined
[4] Torre A,undefined
[5] Pfizer Oncology,undefined
[6] 10646 Science Center Drive,undefined
来源：
British Journal of Cancer | 2010年 / 103卷
关键词：
sunitinib; irinotecan; combination; advanced solid tumours; pharmacokinetics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：993 / 1000
页数：7
相关论文
共 50 条
  • [41] Safety and tolerability of AZD8055 in Japanese patients with advanced solid tumors; a dose-finding phase I study
    Hajime Asahina
    Hiroshi Nokihara
    Noboru Yamamoto
    Yasuhide Yamada
    Yosuke Tamura
    Kazunori Honda
    Yoshitaka Seki
    Yuko Tanabe
    Hitoshi Shimada
    Xiaojin Shi
    Tomohide Tamura
    Investigational New Drugs, 2013, 31 : 677 - 684
  • [42] Phase I study of capecitabine in combination with cisplatin and irinotecan in patients with advanced solid malignancies
    H. Sayar
    Z. Shen
    S. J. Lee
    M. Royce
    I. Rabinowitz
    F. Lee
    H. Smith
    S. Eberhardt
    A. Maestas
    H. Lu
    C. Verschraegen
    Investigational New Drugs, 2009, 27 : 153 - 158
  • [43] A Phase I, Dose-Finding Study in Patients with Advanced Solid Malignancies of the Oral γ-Secretase Inhibitor PF-03084014
    Messersmith, Wells A.
    Shapiro, Geoffrey I.
    Cleary, James M.
    Jimeno, Antonio
    Dasari, Arvind
    Huang, Bo
    Shaik, M. Naveed
    Cesari, Rossano
    Zheng, Xianxian
    Reynolds, Jennifer M.
    English, Patricia A.
    McLachlan, Karen R.
    Kern, Kenneth A.
    LoRusso, Patricia M.
    CLINICAL CANCER RESEARCH, 2015, 21 (01) : 60 - 67
  • [44] Phase I study of capecitabine in combination with cisplatin and irinotecan in patients with advanced solid malignancies
    Sayar, H.
    Shen, Z.
    Lee, S. J.
    Royce, M.
    Rabinowitz, I.
    Lee, F.
    Smith, H.
    Eberhardt, S.
    Maestas, A.
    Lu, H.
    Verschraegen, C.
    INVESTIGATIONAL NEW DRUGS, 2009, 27 (02) : 153 - 158
  • [45] An open-label, dose-finding study of the combination of satraplatin and gemcitabine in patients with advanced solid tumors
    Di Paola, Eugenio Donato
    Alonso, Silvia
    Giuliani, Rosa
    Calabro, Fabio
    DAlessio, Antonietta
    Regine, Giovanni
    Cerbone, Linda
    Bianchi, Laura
    Mancuso, Andrea
    Sperka, Sabine
    Rozencweig, Marcel
    Sternberg, Cora N.
    FRONTIERS IN ONCOLOGY, 2012, 2
  • [46] A PHASE I DOSE ESCALATION STUDY OF SUNITINIB (SU) IN COMBINATION WITH PEMETREXED (PEM) IN PATIENTS (PTS) WITH ADVANCED SOLID MALIGNANCIES
    Chow, L. Q. M.
    Jonker, D. J.
    Laurie, S. A.
    Call, J. A.
    Diab, S. G.
    McWilliam, M.
    Wang, E.
    Chao, R.
    Eckhardt, S. G.
    Camidge, D. R.
    ANNALS OF ONCOLOGY, 2008, 19 : 159 - 159
  • [47] Sunitinib (SU) in combination with pemetrexed (P) in patients (pts) with advanced solid malignancies: A phase I dose escalation study
    Chow, L. Q.
    Jonker, D. J.
    Laurie, S. A.
    Call, J. A.
    Diab, S. G.
    Goss, G.
    McWilliam, M.
    Wang, E.
    Chao, R.
    Eckhardt, S. G.
    Camidge, D. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [48] A phase I study of bevacizumab in combination with sunitinib in advanced solid tumors
    Cooney, M. M.
    Garcia, J.
    Brell, J.
    Dreicer, R.
    Beatty, K.
    Mekhail, T.
    Bukowski, R.
    Zwiebel, J.
    Remick, S. C.
    Rini, B. I.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [49] Phase I dose-escalation study of aflibercept in combination with docetaxel and cisplatin in patients with advanced solid tumours
    G Freyer
    N Isambert
    B You
    S Zanetta
    C Falandry
    L Favier
    V Trillet-Lenoir
    S Assadourian
    K Soussan-Lazard
    S Ziti-Ljajic
    P Fumoleau
    British Journal of Cancer, 2012, 107 : 598 - 603
  • [50] Phase I dose-escalation study of aflibercept in combination with docetaxel and cisplatin in patients with advanced solid tumours
    Freyer, G.
    Isambert, N.
    You, B.
    Zanetta, S.
    Falandry, C.
    Favier, L.
    Trillet-Lenoir, V.
    Assadourian, S.
    Soussan-Lazard, K.
    Ziti-Ljajic, S.
    Fumoleau, P.
    BRITISH JOURNAL OF CANCER, 2012, 107 (04) : 598 - 603
12345